Publication
Annual Epidemiological Report 2013 [2011 data]
Reporting on 2011 surveillance data and 2012 epidemic intelligence data
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Legionnaires’ disease
- Sexually transmitted infections
- Surveillance
- Tuberculosis
- Vaccine preventable diseases
- Vector-borne disease
Publication
Annual Epidemiological Report 2009 [2007 data]
This edition of the Annual Report gives special attention to vaccine-preventable diseases and immunisation programmesin the European Union (EU) and European Economic Area (EEA) countries. This edition was revised January and June 2010 and has authority over the print edition.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Europe
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Sexually transmitted infections
- Surveillance
- Tuberculosis
- Vaccine preventable diseases
- Vector-borne disease
Publication
Annual Epidemiological Report 2012 [2010 data]
The sixth edition of the Annual Epidemiological Report on communicable diseases in Europe provides a comprehensive summary of surveillance data for 2010 and an analysis of the public health threats detected in 2011 through ECDC’s routine epidemic intelligence.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Legionnaires’ disease
- Sexually transmitted infections
- Surveillance
- Tuberculosis
- Vaccine preventable diseases
- Vector-borne disease
Publication
Annual Epidemiological Report 2010 [2008 data]
The fourth edition of the Annual Epidemiological Report on Communicable Diseases in Europe provides a comprehensive summary of surveillance data for 2008.
- Antimicrobial resistance
- Avian influenza virus
- Emerging disease
- Food- and waterborne diseases
- Healthcare-associated infections
- HIV infection
- Influenza in humans, avian origin
- Influenza in humans, seasonal
- Sexually transmitted infections
- Surveillance
- Tuberculosis
- Vaccine preventable diseases
- Vector-borne disease
Publication
First European Communicable Disease Epidemiological Report 2007 [2005 data]
The first European Communicable Disease Epidemiological Report produced by ECDC raised that the most important disease threat in Europe is posed by the micro-organisms that have become resistant to antibiotics.
Publication
Annual Epidemiological Report on Communicable Diseases in Europe 2008 [2006 data]
The main topic for this Annual Epidemiological Report is healthcare-associated infections, including antimicrobial resistance.
Publication
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
- Diphtheria
- Food- and waterborne diseases
- Hepatitis A
- Hepatitis B
- Influenza
- Mass gathering
- Measles
- Meningococcal disease
- Middle East respiratory syndrome coronavirus
- Mumps
- Poliomyelitis
- Public health threat
- Rabies
- Rubella
- Saudi Arabia
- Tetanus
- Travellers' health
- Vaccine preventable diseases
- Vector-borne disease
Publication
Rapid risk assessment: Acute encephalitis associated with infection with Borna disease virus 1, Germany
Borna disease virus 1 (BoDV-1) has been associated with human disease in four cases in Germany resulting in the death of three people. As three of the cases belong to a cluster of solid organ recipients from a single donor, donor-derived BoDV-1 transmission is possible. There is no evidence that the donor had any clinical manifestation of the disease.